Emerging Therapies in Interventional Cardiology

The heart, a vital organ at the core of our circulatory system, functions as a relentless pump, ensuring our body's cells receive the nourishment they need to thrive, and the waste products are efficiently removed. Yet, cardiovascular disease (CVD) remains the leading cause of death globally. A staggering 17.9 million lives are claimed by cardiovascular diseases every year, according to the World Health Organisation.

While traditional open-heart surgery and medical therapies have significantly improved heart disease treatment, many patients still experience symptoms and require repeated interventions. Interventional cardiology, a rapidly evolving field, is addressing these challenges with minimally invasive, catheter-based techniques. Emerging therapies in interventional cardiology offer advancements with greater precision, reduced recovery times, and improved patient outcomes. These developments bring new hope for patients and their families, signifying a future where heart disease is increasingly manageable and, perhaps, even overcome.


Understanding Interventional Cardiology

Cardiology focuses on diagnosing, treating, and preventing heart-related conditions, and interventional cardiology specializes in using minimally invasive procedures to treat cardiovascular diseases, often avoiding the need for open-heart surgery. Today’s interventional cardiologists perform procedures like coronary angioplasty, percutaneous coronary intervention (PCI), transcatheter aortic valve replacement (TAVR), and structural heart interventions. Catheters and specialized devices revolutionize how heart conditions are treated, offering safer, quicker, and more effective options. As research advances, new therapies are emerging, expanding the scope of interventional cardiology:

Transcatheter Aortic Valve Implantation (TAVI)

TAVI, also known as Transcatheter Aortic Valve Replacement (TAVR), is a minimally invasive procedure designed to treat aortic stenosis—where the aortic valve narrows and restricts blood flow. Traditionally, open-heart surgery was required for valve replacement, however TAVI allows the placement of a new valve using a catheter, avoiding the need for major surgery. This therapy has shown great promise in improving survival rates and quality of life, particularly for elderly or high-risk patients.

Renal Denervation Therapy

Hypertension, or high blood pressure, is a major risk factor for cardiovascular diseases, however many patients find their condition difficult to control even with medications. Renal denervation therapy is an emerging catheter-based procedure designed to target and deactivate nerves in the renal arteries, which play a key role in blood pressure regulation. By reducing nerve activity, this therapy offers hope for patients with resistant hypertension, potentially lowering their blood pressure and reducing the risk of heart attacks and strokes.

Transcatheter Mitral Valve Repair (TMVR)

Mitral valve regurgitation, where the mitral valve fails to close properly, leads to backward blood flow in the heart, causing symptoms like shortness of breath and fatigue. Traditionally treated with open-heart surgery, transcatheter mitral valve repair (TMVR) offers a minimally invasive alternative. TMVR involves inserting a catheter with a specialized device into the heart to repair the mitral valve. It has shown success in improving quality of life, especially for patients at high risk for surgery, demonstrating how interventional cardiology is shifting toward patient-friendly, less invasive procedures.

Left Atrial Appendage Closure (LAAC)

Atrial fibrillation (AF), a common heart rhythm disorder, increases the risk of stroke due to blood clots forming in the left atrial appendage (LAA). Blood thinners are often prescribed, but long-term anticoagulation can be difficult for some patients. Left atrial appendage closure (LAAC) is a minimally invasive procedure that seals off the LAA, reducing stroke risk without the need for long-term blood thinners. This therapy offers patients a safer, more sustainable solution, particularly those who cannot tolerate anticoagulants.

Transcatheter Pulmonary Valve Replacement (TPVR)

Patients with congenital heart defects frequently face issues with their pulmonary valve, often requiring surgical intervention. Transcatheter pulmonary valve replacement (TPVR) offers a minimally invasive option, where a catheter is used to insert a valve into the heart to restore proper blood flow. TPVR significantly reduces the need for repeat surgeries, improving both short- and long-term quality of life for patients with pulmonary valve dysfunction.

The field of interventional cardiology continues to rapidly evolve, reshaping the future of heart disease treatment. Minimally invasive techniques are giving patients a new lease on life by offering better outcomes and quicker recovery times. For patients and their families, these advancements represent hope and optimism—a shift from uncertainty to renewed possibilities.

Emerging angioplasty techniques

Advancements in angioplasty have also expanded options for patients with complex cardiovascular conditions:

Angioplasty with Laser: In this method, a laser is used to dissolve blockages in the arteries. It’s like using a focused light to clear out the clogged areas, helping blood flow more easily.

Angioplasty Assisted by Impella: This technique uses a tiny heart pump called an Impella to assist the heart during a procedure. The pump helps support the heart while doctors work to open blocked arteries, making the process safer for patients with severe heart conditions.

Angioplasty with Intravascular Lithotripsy (IVL/Shockwave): IVL uses gentle shockwaves to break up hardened deposits in the arteries. Once the blockages are softened, it's easier for doctors to place stents, which help keep the arteries open and ensure better blood flow.

The article is written by Dr Praveen Chandra, Chairman, Interventional Cardiology, Cardiac Care, Medanta

(DISCLAIMER: The views expressed are solely of the author and ETHealthworld.com does not necessarily subscribe to it. ETHealthworld.com shall not be responsible for any damage caused to any person/organisation directly or indirectly)